The autonomic nervous system regulates the body’s involuntary functions — blood pressure, heart rate, sweating, gastrointestinal motility, urinary control, sexual function, and pupillary responses. It does this continuously, automatically, and almost entirely beneath conscious awareness. When the system fails, the patient complains of dizziness on standing, dry mouth, constipation, urinary urgency, sexual dysfunction, intolerance of heat. The bedside exam of the autonomic nervous system is often left out of routine testing, partly because the abnormalities are subtle and partly because the formal autonomic battery requires a specialized lab. But several useful bedside tests can be done in minutes, and they often change the diagnostic differential entirely.

This page covers the bedside autonomic exam: the tests that can be done at the chair side, the patterns of dysfunction by system involved, and the major autonomic syndromes that the neurologist needs to recognize. The principle throughout: autonomic findings are sensitive markers of central neurodegeneration, of peripheral neuropathy, of immune disease, and of medication effects, and they often appear before the motor and cognitive features that bring the patient to attention.

Functional Overview

The autonomic nervous system has two divisions:

• Sympathetic: thoracolumbar outflow (T1-L2/3), with preganglionic neurons in the intermediolateral cell column of the spinal cord, postganglionic neurons in the sympathetic chain. Mediates the “fight or flight” response: increased heart rate, vasoconstriction, sweating, pupillary dilation, bronchodilation, glycogenolysis, mobilization for action.
• Parasympathetic: craniosacral outflow, with preganglionic neurons in cranial nerve nuclei (III, VII, IX, X) and the sacral cord (S2-S4), postganglionic neurons near or in the target organs. Mediates “rest and digest”: slowed heart rate, increased gut motility, urination, sexual function, pupillary constriction, lacrimation, salivation.

Central autonomic control includes the hypothalamus, the brainstem (especially the medulla, where the cardiovascular and respiratory centers sit), and forebrain regions (insular cortex, cingulate, amygdala). Disorders that affect these centers — strokes, neurodegenerative diseases, autoimmune processes — produce predictable autonomic patterns.

Bedside Tests of Cardiovascular Autonomic Function

Orthostatic Vital Signs

The most useful single autonomic test at the bedside. The patient lies supine for at least three to five minutes, and the blood pressure and heart rate are recorded. The patient then stands, and blood pressure and heart rate are recorded at one minute and at three minutes of standing.

Definitions:

• Classical orthostatic hypotension: a sustained reduction in systolic blood pressure of 20 mmHg or more, or in diastolic blood pressure of 10 mmHg or more, within three minutes of standing.
• Initial orthostatic hypotension: a transient (less than thirty seconds) drop of more than 40 mmHg systolic on standing, often associated with dizziness; this is a separate physiological phenomenon and is best detected by continuous beat-to-beat blood pressure monitoring.
• Delayed orthostatic hypotension: a drop in blood pressure that develops after three minutes of standing, sometimes only after five or ten minutes. Common in mild autonomic neuropathy and in early MSA.
• Postural tachycardia syndrome (POTS): an increase in heart rate of 30 bpm or more (40 bpm in adolescents) within ten minutes of standing, without significant blood pressure drop. Common in young women, often after viral illness or surgery.

The pattern matters more than the absolute numbers. Neurogenic orthostatic hypotension — from autonomic neuropathy or central autonomic failure — shows a drop in blood pressure with little or no compensatory increase in heart rate. The supine heart rate is often slow, and on standing the rate does not rise much (because the cardiac autonomic supply is compromised). Non-neurogenic orthostatic hypotension (from volume depletion or medications) typically shows reflex tachycardia in proportion to the drop in blood pressure.

Valsalva Maneuver

The Valsalva maneuver tests the integrity of the cardiovascular autonomic reflexes. The patient blows into a sphygmomanometer tube to maintain about 40 mmHg of pressure for fifteen seconds (or holds their breath and bears down). Four phases are recognized:

1. Phase I (early strain): brief rise in blood pressure as intrathoracic pressure increases.
2. Phase II (late strain): fall in blood pressure as reduced venous return reduces cardiac output; sympathetic compensation produces tachycardia and vasoconstriction.
3. Phase III (early release): brief further fall as intrathoracic pressure drops suddenly.
4. Phase IV (late release): rise in blood pressure with bradycardia (vagal response to the BP overshoot) as venous return and stroke volume return.

In autonomic failure, the late strain phase shows progressive fall in blood pressure without sympathetic compensation; the late release phase shows little or no blood pressure overshoot and no bradycardia. The Valsalva ratio (highest heart rate during strain divided by lowest heart rate after release) is normally above 1.3-1.4; values below 1.1 are abnormal. Formal interpretation requires continuous beat-to-beat blood pressure monitoring, which is not available at most bedsides, but the bedside assessment of heart rate response to Valsalva is still useful.

Heart Rate Variability with Deep Breathing

The patient breathes deeply at a rate of about six breaths per minute (five seconds in, five seconds out) for at least one minute, while heart rate is monitored. The normal response is a substantial heart rate increase during inspiration and decrease during expiration (sinus arrhythmia), reflecting vagal modulation of cardiac rhythm. The expiratory-to-inspiratory (E:I) ratio of heart rate is normally above 1.2; values below 1.1 suggest reduced vagal tone, often from autonomic neuropathy.

This test is particularly useful in diabetic autonomic neuropathy and in early Parkinson disease, where reduced heart rate variability with deep breathing is an early finding.

Sudomotor Function

Sweating is mediated by sympathetic cholinergic fibers (an unusual combination — sympathetic outflow with acetylcholine as the neurotransmitter). Disorders of sweating can be:

• Anhidrosis: absent sweating in a defined territory. Causes include autonomic neuropathy (often patchy), central lesions (Wallenberg syndrome and other brainstem strokes can produce ipsilateral facial anhidrosis), spinal cord lesions, and skin diseases that destroy sweat glands.
• Hyperhidrosis: excessive sweating, either generalized or focal. Causes include essential hyperhidrosis (idiopathic), hyperthyroidism, autonomic dysreflexia (in cord injury, above the level of the lesion), Frey syndrome (gustatory sweating after parotid surgery from misdirected parasympathetic regeneration), and rare causes such as auriculotemporal syndrome.
• Compensatory hyperhidrosis: increased sweating in unaffected territories in patients with widespread anhidrosis from autonomic neuropathy.

At the bedside, sweating can be assessed by observation and by feeling the skin in different territories. The patient’s history of intolerance to heat (because they cannot sweat), inability to sweat during exercise, or compensatory sweating from one area when another area cannot sweat can be revealing. Formal evaluation requires quantitative sudomotor axon reflex testing (QSART) or thermoregulatory sweat testing in an autonomic laboratory.

Pupillary Autonomic Function

The pupils have separate sympathetic (dilator) and parasympathetic (constrictor) innervation. Pupillary findings are covered in detail on the CN III, IV, VI page. Two specifically autonomic findings:

• Horner syndrome: loss of sympathetic supply to the eye, producing miosis, partial ptosis, and (in proximal lesions) anhidrosis of the face. Causes range from carotid dissection to lateral medullary stroke to Pancoast tumor.
• Adie tonic pupil: postganglionic parasympathetic denervation of the iris, producing a large, sluggish pupil. Often part of Adie syndrome (with depressed deep tendon reflexes) in young women.

Gastrointestinal Autonomic Function

The autonomic nervous system controls gastrointestinal motility, secretion, and sensation. Patient history is the main bedside tool for assessing GI autonomic function:

• Early satiety, postprandial fullness, nausea, vomiting: suggest gastroparesis — common in diabetic autonomic neuropathy and in Parkinson disease.
• Constipation: a frequent feature of generalized autonomic dysfunction. Severe constipation in Parkinson disease often precedes motor symptoms by years and is one of the most reliable prodromal features.
• Diarrhea: less common but seen in diabetic autonomic neuropathy and amyloid autonomic neuropathy. Often alternating with constipation.
• Fecal incontinence: distal autonomic dysfunction, particularly in MSA and amyloid neuropathy.

Urinary and Sexual Autonomic Function

The pelvic autonomics control bladder and sexual function. Pattern of dysfunction:

• Urinary retention: peripheral autonomic neuropathy, MSA, conus medullaris or cauda equina lesions, postoperative.
• Urinary urgency and frequency: spinal cord disease (multiple sclerosis, cervical myelopathy), Parkinson disease.
• Urge incontinence: detrusor overactivity, common in spinal cord and brain disorders.
• Erectile dysfunction: an early feature of many autonomic neuropathies. In Parkinson disease, erectile dysfunction can precede motor symptoms by years.
• Female sexual dysfunction: less often recognized but parallels male erectile dysfunction in autonomic disorders.

The Major Autonomic Syndromes

Diabetic Autonomic Neuropathy

The most common autonomic neuropathy worldwide. Develops over years in patients with poor glycemic control. Features include cardiovascular autonomic dysfunction (reduced heart rate variability, orthostatic hypotension), gastroparesis, constipation alternating with diabetic diarrhea, erectile dysfunction, and sudomotor abnormalities. The diabetic patient with otherwise unexplained dizziness on standing, early satiety, or erectile dysfunction probably has autonomic neuropathy whether tested formally or not.

Multiple System Atrophy (MSA)

A neurodegenerative synucleinopathy characterized by autonomic failure combined with parkinsonism (MSA-P) or cerebellar ataxia (MSA-C). The autonomic features — severe orthostatic hypotension, urinary dysfunction (urgency, retention, or incontinence), and erectile dysfunction — are often the presenting complaints, sometimes years before motor symptoms develop. Severe orthostatic hypotension that is disproportionate to the apparent parkinsonism, and erectile dysfunction in middle-aged men with mild parkinsonism, should raise suspicion for MSA.

Pure Autonomic Failure (PAF)

Isolated, slowly progressive autonomic neuropathy without other neurological features. Patients present in late middle age with orthostatic hypotension, urinary dysfunction, erectile dysfunction, and reduced sweating. The pathology is alpha-synuclein deposition limited to autonomic ganglia. Some patients with apparent PAF later develop Parkinson disease or MSA, suggesting these are points on a synucleinopathy spectrum.

Parkinson Disease

Idiopathic Parkinson disease produces autonomic features in most patients, sometimes preceding motor symptoms by years (the prodromal phase). Constipation, urinary urgency, erectile dysfunction, and reduced heart rate variability are common. Severe early orthostatic hypotension should raise suspicion of MSA rather than idiopathic PD.

Postural Tachycardia Syndrome (POTS)

Affects predominantly young women. Symptoms include lightheadedness, palpitations, fatigue, brain fog, and exercise intolerance, with the diagnostic finding of significant heart rate rise on standing without significant blood pressure drop. Often triggered by viral illness, surgery, or pregnancy. Treatment includes salt and fluid expansion, compression garments, exercise reconditioning, and sometimes pharmacological agents.

Autoimmune Autonomic Ganglionopathy (AAG)

Subacute pandysautonomia with antibodies to the ganglionic acetylcholine receptor (gAChR). Presents with severe autonomic failure across all systems (cardiovascular, GI, urinary, sudomotor, pupillary) over weeks to months. Treatment is immunosuppression (steroids, IVIG, plasma exchange, rituximab).

Familial Dysautonomia (Riley-Day Syndrome)

Hereditary autonomic and sensory neuropathy seen almost exclusively in Ashkenazi Jewish patients. Presents in infancy with autonomic crises, absent fungiform papillae, and characteristic clinical features.

Spinal Cord Injury

Spinal cord injuries above T6 produce a particular autonomic syndrome — autonomic dysreflexia — in which a noxious stimulus below the level of the lesion (most commonly bladder distension) triggers a sympathetic surge with severe hypertension, headache, and sweating above the level of the lesion. The patient may also have flushing and bradycardia from the baroreflex response above the level. Recognition is important because the hypertension can be severe enough to cause stroke or seizure; treatment is removing the noxious trigger.

Carotid Sinus Hypersensitivity

Excessive baroreflex response to carotid pressure, producing bradycardia (cardioinhibitory type) or hypotension (vasodepressor type) on neck pressure. Recurrent syncope in older patients, particularly during shaving, head turning, or wearing tight collars. Diagnosis is by carotid sinus massage with continuous monitoring; treatment is pacemaker (for cardioinhibitory type) or behavioral modifications.

🔍 Did You Know?

Severe constipation precedes the motor symptoms of Parkinson disease by an average of five to ten years in the prospective Honolulu Heart Program and other epidemiological studies. The constipation is thought to reflect early alpha-synuclein pathology in the enteric nervous system, which appears to be one of the first sites of synucleinopathy. Combined with other prodromal features (REM sleep behavior disorder, anosmia, depression, mild cognitive symptoms), severe early constipation is one of the markers used in research to identify patients at high risk of incident Parkinson disease.

Pitfalls and Pearls

• Orthostatic vitals are mandatory in any patient with autonomic complaints. Five minutes lying, then standing for at least three minutes with recordings at one and three minutes.
• The heart rate response distinguishes neurogenic from non-neurogenic orthostatic hypotension. Absent compensatory tachycardia points to autonomic failure.
• Severe early orthostatic hypotension in a parkinsonian patient is MSA until proven otherwise. Idiopathic PD has milder autonomic features early.
• Constipation, erectile dysfunction, and REM sleep behavior disorder are prodromal features of Parkinson disease and synucleinopathies. They may precede motor symptoms by years.
• POTS is common in young women after viral illness. Recognize the syndrome — exaggerated tachycardia on standing without significant BP drop — and treat with salt expansion, exercise, and supportive measures.
• Autonomic dysreflexia is a medical emergency. In a patient with high cord injury and severe hypertension with headache and sweating, look for and remove the noxious trigger (usually bladder distension or fecal impaction).
• Always check for blood pressure variability and orthostasis in patients with diabetes, parkinsonism, paraneoplastic syndromes, and amyloidosis. Asymptomatic autonomic neuropathy is a stroke and cardiovascular risk factor and warrants treatment.
• Treatment of orthostatic hypotension includes non-pharmacological measures (salt and fluid intake, compression stockings, head-of-bed elevation, avoiding triggers) before pharmacological agents (fludrocortisone, midodrine, droxidopa, pyridostigmine).
• Medication review is the commonest bedside confounder. Antihypertensives (especially alpha-blockers, diuretics, beta-blockers), nitrates, tricyclics, antipsychotics, antiparkinsonian drugs (dopamine agonists, levodopa), opioids, SSRIs, anticholinergics, alpha-1 blockers used for BPH (tamsulosin), and PDE5 inhibitors all produce or worsen orthostatic hypotension. Polypharmacy in older adults amplifies the effect. Always reconcile the full medication list — including over-the-counter agents and recent additions — before attributing orthostatic findings to neurogenic disease.

References

1. Campbell WW. DeJong’s The Neurologic Examination. 7th ed. Philadelphia: Lippincott Williams & Wilkins; 2013. Chapter 45.
2. Goldstein DS. Adrenaline and the Inner World. Johns Hopkins University Press; 2006.
3. Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Auton Neurosci. 2011;161(1-2):46-48.
4. Gibbons CH, Schmidt P, Biaggioni I, et al. The recommendations of a consensus panel for the screening, diagnosis, and treatment of neurogenic orthostatic hypotension. J Neurol. 2017;264(8):1567-1582.
5. Kaufmann H, Norcliffe-Kaufmann L, Palma JA. Baroreflex dysfunction. N Engl J Med. 2020;382(2):163-178.
6. Wenning GK, Stankovic I, Vignatelli L, et al. The Movement Disorder Society criteria for the diagnosis of multiple system atrophy. Mov Disord. 2022;37(6):1131-1148.
7. Vernino S, Sandroni P, Singer W, Low PA. Autonomic ganglia: target and novel therapeutic tool. Neurology. 2008;70(20):1926-1932.